FOSTER & MOTLEY INC

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1163902 CINCINNATI, OH

Position in HRMY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$686,947

+$6,837 QoQ

Shares Held

18,867

-22.3% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#162

of 325 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FOSTER & MOTLEY INC holds $3,006,943 across 4 Biotechnology names. HRMY ranks #2 (22.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	25,501	$1,995,963
2	HRMY	Harmony Biosciences Holdings, Inc. This page	18,867	$686,947
3	VRTX	Vertex Pharmaceuticals Inc / Ma	414	$205,646
4	SPRY	ARS Pharmaceuticals, Inc.	14,780	$118,387

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$686,947	18,867	-22.3%	Shares	Sole	2026-08-07
2026-03-31	$680,110	24,281	+4.6%	Shares	Sole	2026-04-21
2025-12-31	$868,480	23,209	-5.0%	Shares	Sole	2026-01-15
2025-09-30	$673,401	24,434	-3.4%	Shares	Sole	2025-10-23
2025-06-30	$799,164	25,290	+139.5%	Shares	Sole	2025-07-29
2025-03-31	$350,453	10,559	—	Shares	Sole	2025-05-08
No filing history on record for this holder in this stock.